Relmada Therapeutics (RLMD) Assets (2012 - 2026)
Relmada Therapeutics (RLMD) recorded Assets of $219.06 million in Q2 2026, up 937.4% from $21.12 million a year earlier but down 6.9% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Assets (2012 - 2026) Analysis & Trends
At the end of FY2025, Relmada Therapeutics reported Assets of $94 million, up 105.2% from FY2024.
- Annual Assets has a five-year compound annual growth rate of -4.5% (FY2020 to FY2025).
- Across earlier years, Assets came in at $45.82 million in FY2024 (-53.0%), $97.55 million in FY2023 (-36.2%), $152.91 million in FY2022 (-31.5%) and $223.33 million in FY2021 (+89.0%).
- Quarterly Assets has ranged from $14.88 million in Q3 2025 to $235.36 million in Q1 2026 over the past five years.
- On a year-over-year basis, Assets has increased for three consecutive quarters, with growth averaging 185.0% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 937.4% in Q2 2026, against a decline of 73.3% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $235.36 million (Q1 2026), $94 million (Q4 2025) and $14.88 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Relmada Therapeutics | 404.28 Mn | 404.28 Mn | - | 219.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 219.06 Mn |
| Mar 31, 2026 | 235.36 Mn |
| Dec 31, 2025 | 94.00 Mn |
| Sep 30, 2025 | 14.88 Mn |
| Jun 30, 2025 | 21.12 Mn |
| Mar 31, 2025 | 27.68 Mn |
| Dec 31, 2024 | 45.82 Mn |
| Sep 30, 2024 | 55.72 Mn |
| Jun 30, 2024 | 71.03 Mn |
| Mar 31, 2024 | 84.41 Mn |
| Dec 31, 2023 | 97.55 Mn |
| Sep 30, 2023 | 109.15 Mn |
| Jun 30, 2023 | 122.04 Mn |
| Mar 31, 2023 | 135.57 Mn |
| Dec 31, 2022 | 152.91 Mn |
| Sep 30, 2022 | 187.12 Mn |
| Jun 30, 2022 | 215.77 Mn |
| Mar 31, 2022 | 225.81 Mn |
| Dec 31, 2021 | 223.33 Mn |
| Sep 30, 2021 | 90.93 Mn |
API Access
Relmada Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();